Alpine Woods Capital Investors’s Novartis NVS Stock Holding History

Alpine Woods Capital Investors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-191,952	Closed	-$13.9M	–	331
2018 Q1	$13.9M	Hold	191,952	–	–	0.74%	45
2017 Q4	$14.4M	Sell	191,952 -1,004	-0.5%	-$75.8K	0.72%	40
2017 Q3	$14.8M	Hold	192,956	–	–	0.76%	37
2017 Q2	$14.4M	Sell	192,956 -952	-0.5%	-$67.5K	0.77%	38
2017 Q1	$12.9M	Buy	193,908 +13,503	+7%	+$900K	0.69%	45
2016 Q4	$11.8M	Sell	180,405 -1,451	-0.8%	-$94.1K	0.65%	50
2016 Q3	$12.9M	Hold	181,856	–	–	0.71%	48
2016 Q2	$13.4M	Sell	181,856 -54,333	-23%	-$3.75M	0.8%	40
2016 Q1	$15.3M	Sell	236,189 -5,915	-2%	-$402K	0.89%	26
2015 Q4	$18.7M	Sell	242,104 -20,534	-8%	-$1.63M	1%	20
2015 Q3	$21.6M	Sell	262,638 -49,104	-16%	-$4.37M	1.18%	9
2015 Q2	$27.5M	Sell	311,742 -33,480	-10%	-$3.07M	1.4%	5
2015 Q1	$30.5M	Buy	345,222 +33,480	+11%	+$2.97M	1.55%	4
2014 Q4	$25.9M	Sell	311,742 -20,200	-6%	-$1.67M	1.33%	6
2014 Q3	$28M	Sell	331,942 -17,787	-5%	-$1.44M	1.49%	6
2014 Q2	$28.4K	Sell	349,729 -28,646	-8%	-$2.25M	0.74%	7
2014 Q1	$28.8M	Hold	378,375	–	–	1.59%	5
2013 Q4	$27.3M	Sell	378,375 -6,696	-2%	-$465K	1.56%	6
2013 Q3	$26.5M	Sell	385,071 -49,774	-11%	-$3.29M	1.63%	8
2013 Q2	$27.6M	Buy	+434,845	New	+$28.3M	1.76%	7

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Alpine Woods Capital Investors's NVS Position: Q2 2018 in Review

Alpine Woods Capital Investors sold out of Novartis (NVS) in Q2 2018, closing a stake of 191,952 shares — an estimated $13.9M sold.

Alpine Woods Capital Investors first reported a position in NVS in Q2 2013 and held it in 20 quarters. The position peaked at $30.5M in Q1 2015. 988 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

Alpine Woods Capital Investors reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
Alpine Woods Capital Investors sold 191,952 Novartis shares in Q2 2018, an estimated $13.9M.
Alpine Woods Capital Investors first reported a position in Novartis in Q2 2013 and held it in 20 quarters.
Alpine Woods Capital Investors's Novartis position peaked at $30.5M in Q1 2015.
988 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2018, filed 9 Aug 2018.